Neoplasia: Benign vs Malignant Tumors & Hallmarks of Cancer

Added:

Neoplasia Basics
Tumor Components & Naming
Malignant Tumor Nomenclature
Benign vs Malignant Features
Hallmarks of Cancer I
Hallmarks of Cancer II
Invasion & Metastasis
Clinical Consequences

Neoplasia Basics

0:02
Playing Section
  • 1

    Defines neoplasia as new growth from acquired mutations in a single cell.

  • 2

    Explains clonal nature, autonomous proliferation, and dependence on body nutrients.

  • 3

    Distinguishes benign tumors from malignant cancers based on behavior.

The eukaryotic cell cycle and its regulation, including major checkpoints and the role of cyclins and cyclin-dependent kinases (CDKs).
Basic genetics, specifically DNA replication, mutation types, and the distinction between proto-oncogenes and tumor suppressor genes.
Normal cellular histology and concepts of cellular adaptation, such as hypertrophy, hyperplasia, metaplasia, and dysplasia.
Fundamental cell signaling pathways that govern cell growth, survival, and programmed cell death (apoptosis).
The TNM staging system and histopathological grading methods used to assess tumor progression and prognosis.
Advanced molecular mechanisms of metastasis, including epithelial-to-mesenchymal transition (EMT) and organotropism.
Principles of cancer therapeutics, ranging from traditional chemotherapy to targeted therapies and modern immunotherapies like checkpoint inhibitors.
Diagnostic oncology techniques, including immunohistochemistry (IHC), tumor markers, and molecular diagnostics (e.g., next-generation sequencing).
278.3K views5Klikes26:44@medtodayOriginal Release: 2020-11-20

Neoplasia, meaning 'new growth,' refers to abnormal tissue masses arising from a single cell with acquired mutations, resulting in clonal proliferation; tumors are classified as benign (localized, non-invasive, easily removable) or malignant (cancerous, invasive, metastasizing), with malignant tumors characterized by eight fundamental hallmarks including self-sufficiency in growth signals, insensitivity to growth inhibitors, altered metabolism, evasion of apoptosis, limitless replicative potential, sustained angiogenesis, ability to invade and metastasize, and immune escape, which collectively explain cancer development and progression.